Azor and Pulmonary oedema - a phase IV clinical study of FDA data

Summary:

Pulmonary oedema is reported as a side effect among people who take Azor (amlodipine besylate; olmesartan medoxomil), especially for people who are male, 50-59 old, have been taking the drug for 6 - 12 months also take Lasix, and have Multiple myeloma.

The phase IV clinical study analyzes which people have Pulmonary oedema when taking Azor. It is created by eHealthMe based on reports of 3,584 people who have side effects when taking Azor from the FDA, and is updated regularly.

What is Azor?

Azor has active ingredients of amlodipine besylate; olmesartan medoxomil. It is often used in high blood pressure. eHealthMe is studying from 3,922 Azor users. Check the latest studies of Azor.

What is Pulmonary oedema?

Pulmonary oedema (fluid accumulation in the lungs) is found to be associated with 1,849 drugs and 1,965 conditions by eHealthMe. Check the latest studies of Pulmonary oedema.

On Jul, 10, 2026

3,584 people reported to have side effects when taking Azor.
Among them, 21 people (0.59%) have Pulmonary oedema.

Among these 21 people:

How long have people been on Azor when they have Pulmonary oedema? *

What is the gender of people who have Pulmonary oedema when taking Azor? *

female: 38.1 %
male: 61.9 %

What is the age of people who have Pulmonary oedema when taking Azor? *

What are other drugs people take besides Azor? *

What are other side effects people have besides Pulmonary oedema? *

Cardiac Failure Congestive: 18 people, 85.71%
Weakness: 17 people, 80.95%
Dyspnea (difficult or laboured breathing): 17 people, 80.95%
Fever: 16 people, 76.19%
Fainting (loss of consciousness and postural tone): 16 people, 76.19%
Hypotension (abnormally low blood pressure): 16 people, 76.19%
Emotional Distress: 16 people, 76.19%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 16 people, 76.19%
Fatigue (feeling of tiredness): 14 people, 66.67%
Atherosclerosis (disorder of the arteries): 14 people, 66.67%

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 16 people, 76.19%
Asthma: 4 people, 19.05%
Pain: 3 people, 14.29%
Dizziness: 3 people, 14.29%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 3 people, 14.29%
Pyogenic Liver Abscess (liver abscess caused by bacteria): 1 person, 4.76%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 4.76%
Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 1 person, 4.76%

* Approximation only. Some reports may have incomplete information.

Do you take Azor and have Pulmonary oedema?

- Check whether Pulmonary oedema is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Azor:

Azor (3,922 reports)

Pulmonary oedema treatments and more:

Pulmonary oedema (53,624 reports)

How severe was Pulmonary oedema and when was it recovered:

Pulmonary oedema in Azor

Expand to all the drugs that have ingredients of amlodipine besylate; olmesartan medoxomil:

Pulmonary oedema and drugs with ingredients of amlodipine besylate; olmesartan medoxomil

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Azor:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Pulmonary oedema:

Pulmonary oedema (1,849 drugs)

Browse all the conditions that are associated with Pulmonary oedema:

Pulmonary oedema (1,965 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on amlodipine besylate; olmesartan medoxomil (the active ingredients of Azor) and Azor (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.